| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer (NCT00601406) | The Christie NHS Foundation Trust | 2006-03-01 |
| Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies (NCT00315861) | SCRI Development Innovations, LLC | 2006-03-01 |
| A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients (NCT00373620) | Korean Gynecologic Oncology Group | 2006-01-01 |
| Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas (NCT00495235) | M.D. Anderson Cancer Center | 2005-10-01 |
| Laparoscopic Approach to Cancer of the Endometrium (NCT00096408) | Queensland Centre for Gynaecological Cancer | 2005-10-01 |
| Endometrial Polyps: Pathophysiology and Clinical Consequences (NCT00247923) | Ullevaal University Hospital | 2005-10-01 |
| Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer (NCT00267488) | GlaxoSmithKline | 2005-10-01 |
| Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients (NCT00268918) | Dana-Farber Cancer Institute | 2005-09-01 |
| AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED) (NCT00122343) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer (NCT00258362) | Masonic Cancer Center, University of Minnesota | 2005-07-01 |
| Physical Activity After Endometrial Cancer (NCT00501761) | M.D. Anderson Cancer Center | 2005-05-01 |
| Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer (NCT00171808) | Novartis Pharmaceuticals | 2005-04-01 |
| Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer (NCT00295945) | University of California, San Francisco | 2005-03-01 |
| Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission (NCT00262938) | Case Comprehensive Cancer Center | 2005-02-01 |
| The Role of Functional MRI and Doppler Sonography in Assessing Blood Vessel Formation Within the Tumors of Endometrial Cancer Patients (NCT00166985) | National Taiwan University Hospital | 2004-09-01 |
| Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer (NCT00388154) | M.D. Anderson Cancer Center | 2004-08-01 |
| Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function (NCT00173290) | National Taiwan University Hospital | 2004-07-01 |
| Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) (NCT00085332) | Gynecologic Oncology Group | 2004-07-01 |
| RAD001 in Recurrent Endometrial Cancer Patients (NCT00087685) | M.D. Anderson Cancer Center | 2004-06-01 |
| Chemoradiation-Induced Nausea and Emesis: Quality of Life (NCT00394602) | M.D. Anderson Cancer Center | 2004-04-07 |
| Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer (NCT00245050) | Case Comprehensive Cancer Center | 2004-04-01 |
| Molecular Staging of Endometrial Cancer (NCT00340808) | National Cancer Institute (NCI) | 2004-03-19 |
| Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer (NCT00287885) | Masonic Cancer Center, University of Minnesota | 2004-03-01 |
| Exemestane in Advanced and Recurrent Endometrial Carcinoma (NCT01965080) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2004-03-01 |
| A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35 (NCT00161226) | University of Medicine and Dentistry of New Jersey | 2004-02-01 |
| Disseminated Endometrial Cancer Cells During Sonohysterography (NCT00205023) | University of Wisconsin, Madison | 2004-01-01 |
| Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC) (NCT00250016) | University of New Mexico | 2003-08-01 |
| Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma (NCT00053794) | NCIC Clinical Trials Group | 2003-06-09 |
| Racial Disparity in Endometrial Cancer (NCT00375804) | University of Louisville | 2003-06-01 |
| Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) (NCT00249990) | University of New Mexico | 2003-04-01 |
| Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy (NCT00508703) | M.D. Anderson Cancer Center | 2003-03-05 |
| Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma (NCT00595725) | Memorial Sloan Kettering Cancer Center | 2003-02-01 |
| Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer (NCT00339651) | National Cancer Institute (NCI) | 2002-11-25 |
| END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin (NCT00401635) | National Cancer Institute, Naples | 2002-11-01 |
| Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer (NCT00052312) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-09-01 |
| External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer (NCT00376844) | Leiden University | 2002-05-01 |
| Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery (NCT00448643) | University of Miami | 2002-05-01 |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis (NCT00033605) | Alliance for Clinical Trials in Oncology | 2002-04-01 |
| Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer (NCT00033358) | National Cancer Institute (NCI) | 2002-02-01 |
| Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer (NCT00030485) | National Cancer Institute (NCI) | 2002-01-01 |
| Estrogen, Diet, Genetics and Endometrial Cancer (NCT00587886) | Memorial Sloan Kettering Cancer Center | 2001-09-25 |
| Mifepristone for Patients With Endometrial Cancer and LGESS (NCT00505739) | M.D. Anderson Cancer Center | 2001-09-01 |
| Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer (NCT01686256) | Endocyte | 2001-08-01 |
| Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer (NCT00032162) | AGO Study Group | 2001-08-01 |
| Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT00023894) | Gynecologic Oncology Group | 2001-07-01 |
| Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer (NCT00022620) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-06-01 |
| Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer (NCT00016341) | Gynecologic Oncology Group | 2001-05-01 |
| Papillary Serous Carcinoma of the Endometrium (NCT00515073) | M.D. Anderson Cancer Center | 2001-04-01 |
| A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment (NCT00190697) | Eli Lilly and Company | 2001-01-01 |
| Endometrial Cancer - LOHP Alone and With 5FU (NCT00612495) | Sanofi | 2001-01-01 |
| Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors (NCT00010829) | National Center for Complementary and Integrative Health (NCCIH) | 2001-01-01 |
| Thalidomide in Treating Patients With Gynecologic Sarcomas (NCT00006005) | New York University Cancer Institute | 2000-09-01 |
| Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer (NCT00005031) | Gynecologic Oncology Group | 2000-08-01 |
| Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma (NCT01560026) | Taipei Veterans General Hospital, Taiwan | 2000-08-01 |
| Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer (NCT00006027) | Radiation Therapy Oncology Group | 2000-08-01 |
| Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer (NCT00006377) | Memorial Sloan Kettering Cancer Center | 2000-06-01 |
| Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer (NCT00005861) | Gynecologic Oncology Group | 2000-05-01 |
| Chemotherapy in Treating Patients With Sarcoma of the Uterus (NCT00005643) | Gynecologic Oncology Group | 2000-05-01 |
| Bone Mineral Density and Subsequent Cancer Risk (NCT00340262) | National Cancer Institute (NCI) | 2000-04-07 |
| Specimen and Data Study for Ovarian Cancer Early Detection and Prevention (NCT00005095) | Northwestern University | 2000-03-01 |
| Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer (NCT00004251) | NCIC Clinical Trials Group | 2000-01-19 |
| Epidemiological Analysis on Endometrial Cancer in Guangdong Province of China (NCT01761409) | Third Affiliated Hospital, Sun Yat-Sen University | 2000-01-01 |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer (NCT00005583) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2000-01-01 |
| Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer (NCT00071929) | Gynecologic Oncology Group | 1999-11-01 |
| Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors (NCT00004082) | Beth Israel Deaconess Medical Center | 1999-07-01 |
| Quality of Life in Survivors of Gynecologic Cancer (NCT00003795) | Gynecologic Oncology Group | 1999-04-01 |
| Extended Follow-up of Columbia, MO Serum Bank Participants (NCT00340210) | National Cancer Institute (NCI) | 1999-01-14 |
| Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer (NCT00003691) | Gynecologic Oncology Group | 1998-12-01 |
| Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer (NCT00003669) | Eli Lilly and Company | 1998-11-01 |
| Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer (NCT00004915) | Northwestern University | 1998-11-01 |
| Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer (NCT00003179) | Gynecologic Oncology Group | 1998-11-01 |
| Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma (NCT00003718) | Herbert Irving Comprehensive Cancer Center | 1998-09-01 |
| Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00003560) | Herbert Irving Comprehensive Cancer Center | 1998-05-01 |
| Continuation of Follow-up of DES-Exposed Cohorts (NCT00340600) | National Cancer Institute (NCI) | 1998-03-18 |
| Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer (NCT00003267) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-02-01 |
| S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer (NCT00003127) | SWOG Cancer Research Network | 1998-02-01 |
| Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer (NCT00003821) | Genzyme, a Sanofi Company | 1998-01-01 |
| Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer (NCT00003135) | The University of Texas Health Science Center, Houston | 1997-11-01 |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors (NCT00019331) | National Cancer Institute (NCI) | 1997-10-01 |
| Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer (NCT00002976) | Gynecologic Oncology Group | 1997-06-01 |
| Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract (NCT00003334) | NYU Langone Health | 1997-03-01 |
| S9630, Medroxyprogesterone in Treating Women With Breast Cancer (NCT00002920) | SWOG Cancer Research Network | 1997-03-01 |
| Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery (NCT00002807) | NCIC Clinical Trials Group | 1996-07-04 |
| Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis (NCT00002949) | University of Chicago | 1996-07-01 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma (NCT00002764) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-04-01 |
| A Follow-up Study of Women Evaluated and Treated for Infertility (NCT00342446) | National Cancer Institute (NCI) | 1995-10-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma (NCT00002641) | European Organisation for Research and Treatment of Cancer - EORTC | 1995-02-01 |
| The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) (NCT01447199) | M.D. Anderson Cancer Center | 1994-09-01 |
| Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer (NCT00002493) | Gynecologic Oncology Group | 1992-05-01 |
| The French E3N Prospective Cohort Study (NCT03285230) | Institut National de la Santé Et de la Recherche Médicale, France | 1990-06-15 |
| Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus (NCT00002459) | European Organisation for Research and Treatment of Cancer - EORTC | 1988-04-01 |
| High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma (NCT00002465) | St. Vincent Medical Center - Los Angeles | 1987-12-01 |
| Karyopharm Expanded Access Program for Selinexor (NCT07215832) | Karyopharm Therapeutics Inc | |
| Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors (NCT04681248) | Leap Therapeutics, Inc. | |
| Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells (NCT01267461) | Meir Medical Center | |
| Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer (NCT00482300) | University of Roma La Sapienza | |